Skip to main content

ACETOMENAPHTHONE (VITAMIN K3)FAT SOLUBLE

 ACETOMENAPHTHONE (VITAMIN K3) FAT SOLUBLE


BRAND NAME:-ACETOMENADIONE 5,10mg tab; KAPILIN 10mg tab.


ACETOMENAPHTHONE is a fat soluble dietary principal for the synthesis of clotting factors, which promote coagulation and are indicated in haemorrhagic states.



CHEMISTRY AND SOURCE:- Vit K has a basic naphthoquinone structure, with or without a side chain (R) at position 3. The side chain in K1 is phytyl ,in K2 prenyl , while in K3 there is no side chain.


ACTION:- VITAMIN K3 acts as a cofactor at a late stage in the synthesis by liver of coagulation protein — prothrombin, factors VII,IX and X. The vit K dependent change (y carboxylation of glutamate residues of these zymogen proteins; confers on them the capacity to bind Ca2+ and to get bound to phospholipids surface — properties essential for participation in the coagulation cascade.



UTILISATION:- Fat- soluble froms of vit K are absorbed from the intestine via lymph and require bile salts for absorption, while water soluble froms are absorbed directly into portal blood. An active transport process in the jejunum has been demonstrated for K3 are absorbed by simple diffusion. Vit K is only temporarily concentrated in liver,but there are no significant Store in the body. It is metabolized in liver by side chain cleavage and glucuronide conjunction; metabolites are excerted in bile and urine. 


USE:- Prophylaxis and treatment of Bleeding due to deficiency of clotting factors. Dietary deficiency, prolonged Antimicrobial therapy, obstructive jaundice or malabsorption syndrome, liver disease etc.


ADVERSE EFFECTS:- 

allergic reaction,skin rashes,g.i.t 

Comments

Popular posts from this blog

Cefpodoxime proxetil Uses, Side Effects, and More

 Cefpodoxime proxetil Brand name:- cefoprox ,cepodem,DOXCEF 100,200mg cap.  Cefpodoxime Proxetil is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive. Pharmacodynamic:-  Cefpodoxime is shown to be effective against most Gram positive and Gram negative bacteria, except Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Mechanism of action:-  Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime. Cefpodoxime is inactivated by certain extended spectrum beta-lactamases. The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. The active metabolite of cefpodoxime binds preferentially to penicilli

Cephalexin ( ZYD ) ( Cefalexin ) Uses, Side Effects, and More

 Cephalexin (ZYD) (Cefalexin) Brand name:-  Cephacillin 250,500mg cap; Sporidex, Alcephin,Cephaxin cap. Cephalexin (also called Cefalexin)  is the most common used orally effective first generation cephalosporin , similar in spectrum to cefazolin , but less active against penicillinase producing staphylococci and H. Influenza. Plasma protein binding is low; it attains High concentration in bile and is excreted unchanged in urine; t½ - 60min. Pharmacodynamic:-  Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations.Label It is effective against most gram-positive bacteria through its inihibition of the cross linking reaction between N-acetyl muramicacid and N-acetylglucosamine in the cell wall, leading to cell lysis. Pharmacokinetics:- Cephalexin is rapidly and almost completely absorbed from t

BASILIXIMAB Uses, Side Effects, and More

 BASILIXIMAB BRAND NAME:- Simulect   BASILIXIMAB is another anti CD - 25 antibody with higher affinity for the IL-2 receptor, but shorter plasma t½ (1 week) . is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used in combination with other medicines used to prevent organ rejection. PHARMACODYNAMIC:- Basiliximab functions as an IL-2 receptor antagonist. Specifically it inhibits IL-2-mediated activation of lymphocytes, a critical pathway in the cellular immune response involved in allograft rejection.  MECHANISM OF ACTION:-  Basiliximab competes with IL-2 to bind to the alpha chain subunit of the IL2 receptor on the surface of the activated T lymphocytes and thus prevents the receptor from signaling. This prevents T cells from replicating and also from activating B cells, which are responsible for the production of antibodies, which would bind to the trans